Human Genetics Market report predicts impressive growth by 2027 just published

 Human Genetics Market

Human genetics is the broad field of studying human inheritance and comprises sub-sections such as cytogenetics, molecular genetics, genetic counseling, clinical genetics, and others. It helps to understand gene functionalities and the consequences of abnormalities in them. Through human genetics, the human genome is studied to diagnose genetic disorders and provide related treatment much more efficiently.

The global human genetics market is expected to have a market value of USD 1,12,536.54 million by 2027.The growth of human genetics is driven by the growing adoption of genetic testing. However, high cost of genetic testing is likely to restrain the market growth.  

Major Key Players:

MRFR recognizes the following companies as the key players in the global human genetics market— Myriad Genetics (US), Synlab Group (Germany), Eurofins Megalab S.A (Spain), Biomarker Technology (US), Echevarne Laboratory (Spain), Elabscience Biotechnology Inc (US), NIMGenetics (Spain), Sistemas Genómicos (Spain), FullGenomics (Spain), GENinCode (UK), Atrys Health (Spain), Genyca (Spain), Igenomix (India), Genologica (Spain), Bode Technology Group Inc (US).

Key Findings of the Study

US accounted for the largest share of the global human genetics market due to the increasing demand for genetic testing by the population are driving the market in the region. For instance, according to Healthline Media (US), in October 2019, United HealthCare Services, Inc. (US), the largest health insurance company in the US, started providing insurance coverage for multi-panel genetic testing. According to the National Institutes of Health (NIH), in July 2022, over 77,000 genetic tests are currently used in the US, and more are under development.

Regional Analysis

The global human molecular genetics market, based on region, has been divided into US, Canada, UK, Germany, Spain, Japan, others.

The human genetics market in the US benefits from a high healthcare expenditure, increasing demand for genetic testing by the population, and high public awareness regarding early detection of diseases and preventive care. Moreover, the availability of reimbursements in the US for genetic tests further improves market growth in the country. For instance, in October 2019, United HealthCare Services, Inc. (US), the largest health insurance company in the US, started providing insurance coverage for multi-panel genetic testing. According to the National Institutes of Health (NIH), in July 2022, over 77,000 genetic tests are currently used in the US, and more are under development.

Public-funded genetic testing in Canada is highly restricted and is only available to a select few who fall into certain criteria, such as a family history of cancer and early onset of cancer. Additionally, people in Canada who want their genetic testing done can opt for direct-to-consumer genetic tests such as color and invitae. Results from these tests can then be consulted with genetic counselors. Furthermore, there are human genetics programs to test patients with genetic disorders across Canada. For instance, the Hereditary Cancer Program is based in British Columbia, Canada, conducting genetic counseling and tests to detect hereditary cancer.

Clinically directed genetic testing has been available for several decades in the NHS for predictive testing for family members and molecular genetic investigation of a clinical presentation. Genomic health data in the UK is generated in three major areas, including large-scale research programs, the healthcare system, and purchasing of direct-to-consumer genetic testing. Moreover, the rise in the number of initiatives undertaken by the public as well as private organizations is further aiding the market growth. For instance, in April 2022, GEN inCode UK Limited announced its collaboration with Royal Brompton and Harefield hospitals (RB&H) for providing cardiovascular disease clinical genetic testing and reporting. In August 2022, DnaNudge announced the completion of its Series A investment round of USD 60 million led by Ventura Capital

The rising prevalence of genetic disorders, cancer, increasing awareness and acceptance regarding personalized medicines, and growing focus on R&D activities contribute to the country's growth. As per the data published by Global Cancer Observatory in March 2022, cancer accounted for 628,516 new cases and 252,065 deaths in Germany in 2022. In addition, the government is implementing a number of favorable and collaborative policies to incorporate genetic testing into the healthcare system and provide insurance reimbursements to citizens, which, in turn, is driving the market growth.

Segmentation

The global human genetics market is segmented into application, end user and region. The application segment is further segmented into wellness & E-commerce, preventive medicine, diagnostic & treatment. The diagnostic & treatment segment is further sub-segmented into oncology, cardiology, assisted reproduction, neurology, gynecology, others. The neurology segment is further sub-segmented into neuropediatric, others. The test segment is further segmented into NIPT, carrier testing, pharmacogenomic testing, karyotype testing, thrombophilia testing, septin 9 biomarker testing, NGS, others. The NGS segment is further sub-segmented into oncology, cardiology, others.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Retina Health Market Forecast to 2030 Detailed in New Research Report

 Retina Health Market

One of the main reasons influencing the market is the rising occurrences of visual impairment and myopia population, notably during the COVID-19 pandemic, due to increased screen usage and participation in virtual meetings while working from home. High myopia is associated with a higher chance of developing several chronic eye conditions, including cataracts, glaucoma, and age-related macular degeneration. The market is also being driven by an increase in the choice of eye health supplements among older people and millennials who are more prone to digital eye strain and myopia. The number of retinal illnesses such as diabetic retinopathy and diabetic macular edema is increasing due to the increased incidence of diabetes in emerging economies.

By 2030, the retina health market is anticipated to grow at a CAGR of 7.01% and reach USD 24.22 billion.

During the projected period, the market for retinal disease treatments is anticipated to rise as more skilled experts become available around the globe that specialize in the treatment of retinal diseases. Millions of people worldwide are affected by two major retinal diseases, macular degeneration, and diabetic retinopathy. The increasing frequency of retinal disorders worldwide and the increase in strategic initiatives are credited with driving the expansion of the global market for retinal health. Additionally, it is anticipated that the market will experience profitable growth during the projected period due to rising attempts by both public and private organizations to raise awareness about retinal diseases. However, it is projected that the dearth of knowledge about retinal illnesses may impede market expansion.

Major Key Players:

The illustrious contenders in the retina health market are Regenxbio Inc. (US), Spark Therapeutics, Inc. (Us), Gensight Biologics (France), Hemera Biosciences LLC (US), Meiragtx Limited (US), Allergan Plc (Subsidiary Of AbbVie Inc.) (Ireland), Oxford Biomedica Plc (UK), Santen Pharmaceuticals Inc. (Japan), Novartis AG (Switzerland), and Applied Genetic Technologies Corporation (AGTC) (US).

Segment Analysis

By disease indication, the market includes diabetic retinopathy, age-related macular degeneration, inherited retinal diseases, and retinoblastoma. By treatment, the market includes drugs, Retinal Disease Therapeutics, and surgery.

Regional Analysis

Due to several factors, including the high prevalence of retinal illnesses and significant market participants in the region, the North American retina health market is expanding. Due to reasons like the high prevalence of wet AMD, rising diabetes rates, and a large number of elderly individuals, the European retina health market is expanding. Due to its weak economy, inadequate healthcare infrastructure, dearth of qualified experts, and low public awareness, the remainder of the world is predicted to have a slower CAGR than other regions. However, the market is expected to expand significantly throughout the projected period in the Asia-Pacific region. Numerous local market participants supply cutting-edge and reasonably priced eye health supplements, and contract production centers for these products emerged.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Nitrile Gloves Market Forecast to 2027 Detailed in New Research Report

 Medical Nitrile Gloves Market

The global medical nitrile gloves market is expected to have a market value of USD 5,897.81 million by 2027.

Nitrile medical grade gloves are great for use in healthcare fields of any kind seeing as they protect against bodily fluids, blood borne pathogens and are highly puncture resistant. Increasing incidence of COVID-19,increasing demand and shortage of medical nitrile gloves, and the rising concerns about safety and sanitation is driving the market growth of this market.

Major Key Players:

Some of the key players operating in the nitrile gloves manufacturers are Dynarex Corporation (US)., Shield Scientific B.V. (Netherland), Mercator Medical S.A, (Poland), Hartalega Holdings Berhad (Malaysia),Top Glove Corporation Bhd (Malaysia), Kossan Rubber Industries Bhd (KRI) (Malaysia), Ansell Healthcare (US), Medline Industries, In (US), 3M (US), McKesson Corporation (US), Honeywell International Inc (US), Atrium Medical Care (US), Kimberly Clark (US), SHIELD Scientific (France), Supermax Healthcare Limited (UK).

Segment Analysis

The global medical nitrile gloves market based on the type has been segmented into non powdered, powdered. The global medical nitrile gloves market, by usage, has been categorized into disposable, reusable. Based on application, the market is bifurcated into examination, surgical. The global medical nitrile gloves market, by distribution channel, is bifurcated into direct selling, medical store. By end user, the global medical nitrile gloves market, is segmented into hospitals &clinics, diagnostic centers, Ambulatory Surgical Centers (ASCs), rehabilitation centers and others.

Regional Analysis

The global medical nitrile gloves market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World.

The North America has been segmented into market further divided into the US and Canada. The US accounted for the largest share in 2020due to the large number of patients suffering from COVID-19, the high rate of surgical procedures, and the favorable import policies in the region. In addition, the unavailability of enough manufacturers in the region is anticipated to increase the lucrativeness of the market.

The European medical nitrile gloves marke this been further segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Rising government initiatives to promote norms related to safety and to find a cure to the increasing number of cases, and growing healthcare expenditure are the major factors driving the growth of the medical nitrile gloves market in the region. Major manufacturers in the region are opting to acquire a profitable product portfolio to generate steady revenues. For instance, In December 2020, Semperit AG Holding (Austria) took over M&R Dichtungstechnik GmbH (Germany), a manufacturer of profiles for facade construction based in Seligenstadt near Frankfurt, Germany

The market in Asia Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia Pacific. Asia Pacific is expected to register the highest growth rate over the forecast period from 2021 to 2027. This high growth is mainly attributed to the large-scale availability of raw materials, huge export of products from the region, shortage of exam gloves, and dependency of other countries for supplies from the region. Various other factors that influence the growth of the market include the growing cases of infections, the increasing availability of online pharmacies, and the growing number of healthcare professionals working with infectious diseases.

The Rest of the World medical nitrile gloves market is segmented into the Middle East & Africa and Latin America. The market for medical nitrile gloves is growing at a significant rate in the region due to the increasing number of companies and subsidiaries in the region offering products. The availability of glove manufacturers, importers, and suppliers in the region is anticipated to increase market size. Some of the companies in the region include NW Hygiene (South Africa), Evergreen Latex (South Africa), Medinox South Africa (Pty) Ltd, Omnisurge Medical Supplies (South Africa), Uni-medical Limited (Unigloves Nigeria), SafeMed Medical Wholesalers (Zimbabwe), Elreda (Egypt), and others.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Organ-on-a-chip Market Forecast to 2030 Available in New Report

 Organ-on-a-chip Market

Organ-On-a-Chip Market (OOC) is expected to hold a value of USD 115.9 Million by 2030 at a CAGR of 11.80%.

Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers, which contain multiple live human cells in a 3D culture that simulate crucial physiological functions of body organs. These cells are placed in an environment that artificially replicates aspects of the human body, such as morphology, movement, flow, electrical stimuli, and liquid gradients.

The global organ-on-a-chip market is growing owing to various reasons, such as an increase in the number of collaborative sales agreements between pharmaceutical companies and university spin-offs and the availability of advanced models of OOCs in the market. The anticipated launch of advanced organ-specific models and human-on-chip models is expected to further increase the growth rate of this market during the review period.

Grants by government and non-government entities have been the key drivers for the global OOC industry to date. The ability of OOC models to reduce drug development costs drastically will be a key market driver, which is also expected to fuel market growth. However, stringent drug regulatory processes constitute a significant restraint for the widespread use of OOCs by pharmaceutical companies. Drug regulatory authorities scrutinize the preclinical and clinical investigational data of a drug molecule to validate and approve it. The data generated by testing the drug in animal models and humans are required for the drug approval process.

At present, the regulatory authorities do not consider the data obtained by testing the drugs on OOCs sufficient for approval. Data predicting the efficacy of a drug molecule obtained by the chips can be submitted but only along with the trial data from animal and human subjects for the approval process. These drug regulations limit the use of OCCs by end-users are expected to hinder the growth of the global organ-on-a-chip market.

Several market players currently dominate the global organ-on-a-chip market. The key players are involved in product launches and acquisitions to strengthen their market positions.

Major Key Players:

Some of the key players in the Global Organ-On-a-Chip Market are CN Bio Innovations Limited (UK), Emulate, Inc. (US), TissUse GmbH (Germany), MIMETAS BV (Netherlands), Hµrel Corporation, Nortis, Inc. (US), InSphero (Switzerland), TARA Biosystems, Inc. (US), Axosim (US), Organovo Holdings Inc. (US), BioIVT (US), and HemoShear Therapeutics, LLC (US).

Segment Analysis

The global organ on a chip market has been segmented based on organ type, application, and end-user.

The global organ-on-a-chip market has been segregated, based on organ type, into lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain barrier-on-chip, human-on-chip, and others.

The market based on application has been branched into drug discovery, toxicology research, and others. The drug discovery segment is expected to hold the largest share of the market due to the increased application of OOCs by pharmaceutical companies in drug discovery and clinical trials for the different chronic therapeutic areas. The toxicology research segment holds the second-largest share owing to increased R&D, government initiatives and funding for research institutes, and universities on OOCs in toxicology research and drug testing.

By end-user, the market has been classified as pharmaceutical companies, research organizations, and others. The pharmaceutical company’s segment is the largest segment owing to the rise in the number of pharmaceutical companies using OOCs for their R&D and drug toxicity and efficacy testing. The research organization segment is the second-largest segment owing to major universities, research organizations, non-profit research centers that are focusing on the application of OOCs in drug toxicology testing. For instance, the Wyss Institute received almost USD 5.6 million in grant money from the US FDA to use its organ-on-chip technology to test human physiological responses to radiation and to evaluate drugs designed to counter those effects in 2017.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the high prevalence of chronic diseases. The organ-on-a-chip market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European organ-on-a-chip market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The organ-on-a-chip market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

Asia-Pacific is the fastest-growing region in the market. This is mainly due to the increased application of OOCs for drug screening for the treatment of various chronic diseases and a supportive regulatory framework in Asia-Pacific. Such favorable factors are expected to boost market growth during the forecast period.

The organ-on-a-chip market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Artificial Intelligence in Healthcare Market - Global Industry Size, Share, Analysis and Forecast 2022 – 2030

 Artificial Intelligence in Healthcare Market

The healthcare artificial intelligence market is expected to reach USD 12.22 Billion at of 51.9% CAGR during the forecast period 2022-2030. The growing desire to reduce healthcare expenses, as well as increases in processing power and lower hardware costs, boost the healthcare artificial intelligence market. An increase in the number of collaborations and partnerships between various domains in the healthcare ecosystem, as well as a greater need to improve the quality of healthcare services as a result of the disconnect between patients and health workers.

Artificial intelligence allows doctors to use tools that help them diagnose and treat patients more accurately and quickly. However, doctors are hesitant to embrace modern technology, despite patients' increasing preference for them over in-person therapy. With this issue posing a threat to the doctor-patient connection and doctors' reluctance to use AI technology, the healthcare artificial intelligence market is likely to suffer a setback shortly.

Major Key Players:

The major key players in the market are Deep Genomics, Next IT Corp., General Vision, Google, NVIDIA Corporation, IBM Watson Health, Intel Corporation, Koninklijke Philips N.V, General Electric, Stryker, Microsoft Corporation, and CloudMedx Inc.

Segment Analysis

Based on the Component, the global ai in healthcare market has been segmented into Hardware, Software, and Services.

Based on the Application, the global Healthcare Artificial Intelligence (AI) Market has been segmented into Robot-Assisted Surgery, Virtual Nursing assistants, Dosage Error Reduction, Clinical Trial, Preliminary Diagnosis, and Automated Image Diagnosis.

Based on the Technology, the global Healthcare Artificial Intelligence (AI) Market has been segmented into Machine Learning, Querying methods, Natural Language Processing, Context-Aware Computing, and Computer Vision.

Based on the End-User, the global Healthcare Artificial Intelligence (AI) Market has been segmented into Hospital & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, and Academic & Research Laboratories.

Based on the Region, the global Healthcare Artificial Intelligence (AI) Market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World.

Regional Analysis

The Americas has the biggest AI market share in healthcare, which is predicted to continue during the forecast period. A growing biotechnology industry and increasing uses of robot-assisted surgery are two of the key factors that have propelled the Americas to the forefront. An increasing need for better diagnosis and treatment facilities, an increase in demand for digital health systems, and a substantial presence in the area of important AI inventions and product developers are all factors favoring AI in healthcare market development.

Europe is the second-largest sector, because of ongoing R&D in the healthcare AI field. The region's growth pattern is similar to that of the Americas, and the region's business growth is aided by the rapid acceptance of AI in healthcare. The Asia-Pacific region is a fast-growing market with a large number of people seeking high-quality chronic disease treatment. The healthcare sector in the region is quickly expanding due to rising spending.

Meanwhile, the Middle East and Africa would have slower growth than other regions due to a lack of specialized healthcare facilities in parts of the region. The rising healthcare artificial intelligence industry in the MEA region is predicted to have the most impact on business growth.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Sexual Wellness Market | Global Synopsis & Forecast – 2030

 Sexual Wellness Market

The sexual wellness market size was valued USD 77 billion in 2021 and expected to reach USD 112 Billion by 2030 at CAGR of 4.55% during the forecast period 2022-2030.

Sexual health is experience of physical, psychological and social cultural related to sexuality. The products such as, sex toys, condom & contraceptives, sexual enhancement supplements, lubricants, ointments view as a sexual wellness product that provides enjoyment in sexual experience and security.

Increasing global prevalence of Sexually Transmitted Diseases (STDs), increase in awareness regarding sexual health items, and development of e-commerce business are expected to drive the growth of market. According to the Centers for Disease Control and Prevention (CDC), in 2017 around 1,708,569 were suffer with Chlamydia trachomatis infection in US. Similarly, in 2017, around 555,608 were suffer with gonorrhea and 30,644 were suffer with Syphilis in US. Moreover, According to World Health Organization (WHO), every year estimated around 357 million new people suffer with sexually transmitted infections (STIs). Furthermore, according to The Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2017 estimated that 5.2 million suffer with HIV in Asia-Pacific. On other hand, side effects due to toxic ingredients in products and product recalls can restrain the market growth over the assessment period.

Major Key Players:

Some of the prominent players in the global sexual wellness market are LELO (Sweden), Doc Johnson (US), Church & Dwight Co., Inc. (US), Ansell Ltd. (Australia), Reckitt Benckiser Group plc (UK), LifeStyles Healthcare (Australia), Karex Berhad (Malaysia), Veru Inc. (US), Mankind Pharma (India), and BioFilm IP LLC (US).

Segment Analysis

The global sexual wellness industry has been segmented into product and distribution channels.

Based on product, sexual wellness market is segmented into sex toys, condom & contraceptives, sexual enhancement supplements, lubricants, ointments, and others. The sex toys segment is expected to account for the largest share segment of the market in 2017.

Based on distribution channels, sexual wellness market is segmented into retail and online platforms. The retail segment is expected to account for the largest share segment of the market in 2017. Retail segment further sub segmented into drug stores, specialty stores, and others.

Regional Analysis

Geographically, the Americas is expected to dominate the global sexual wellness market owing to the presence of well-established players, increasing prevalence of Sexually Transmitted Diseases (STDs), increase in awareness regarding sexual health items, and developed e-commerce business. Europe is expected to hold the second largest position in the global sexual wellness market. Asia-Pacific is expected to be the fastest growing market owing to the increasing awareness about sexual wellness products and supportive sex education programs. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global sexual wellness market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Fertility Services Market – Industry Share Report 2022

 Fertility Services Market

Global Fertility Services Market is expected to register a CAGR of 6.02% during the forecast period and hit USD 37,357.51 Million by 2027.

Fertility services are procedures or treatments incorporated to cure genetic and fertility issues and assist in conception. These services include Assisted Reproductive Technology (ART) methods and drugs that help single parents, infertile couples, and the Lesbian, Gay, Bisexual, and Transgender (LGBT) community in planning a family.

The declining fertility rate, technological advancements in fertility treatments, growth in the median age of first-time motherhood, and rise in obesity and the consumption of alcohol/cigarettes lead to infertility, which is eventually driving the market for fertility services. According to ESHRE, more than 25 million European Union (EU) citizens are affected by infertility. In France, reimbursement/state funding includes six IUI’s (one IUI per menstruation cycle) and four IVF treatments for women under 43 years of age. These factors support the growth of the global fertility services market.

Major Key Players:

MRFR recognizes the following companies as the Key Players in the Global Fertility Services Market— Merck KGaA, Cook Medical, Irvine Scientific Company Inc., Copper Surgical, Kitazato Cooperation, Vitrolife, Ferring B. V, Invo Bioscience, Monash IVF Group, and Care Fertility.

Segment Analysis

Global Fertility Services Market has been divided based on Underlying Cause and Treatment Type. The market, based on the underlying cause, has been segregated into male infertility and female infertility. Based on treatment type, the global fertility services market is segmented into infertility drugs and assisted reproductive technology (ART).

Regional Analysis

Global Fertility Services Market, based on region, has been divided into the american fertility services, Europe, Asia-Pacific, and the Middle East & Africa. Europe is likely to hold the largest share of the global fertility services market during the assessment period owing to the lower fertility rate, increasing obesity cases, increasing IVF tourism in Spain, and growth in the median age of motherhood. The America market is expected to register substantial growth in the market owing to the high adoption rate for IVF treatment, late pregnancies, well-established healthcare systems, and declining fertility rates. Asia-Pacific is likely to hold the third-largest share of the global fertility services market. The Middle East & Africa market is expected to witness gradual growth due to a well-developed healthcare sector and continuously declining fertility rates. For instance, according to the data mentioned by the World Bank, the fertility rate in the UAE reduced from 6.9% in 1960 to 1.7% in 2016.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Pharmaceutical Contract Manufacturing Market 2022: Size, Share, Analysis and Forecast-2027

 Pharmaceutical Contract Manufacturing Market

Pharmaceutical Contract Manufacturing Market to witness a CAGR of 6.0% to attain a value of USD 174.2 Billion by 2027 owing to the growing investment in R&D activities, asserts Market Research Future (MRFR). The pharmaceutical industry is experiencing a dynamic change. Pricing pressure, pipeline challenges, and emerging markets are redesigning the way companies operate. Pharmaceutical providers need to alter as well. Contract manufacturers that distinguish their abilities and offerings will be able to retain their customers and expand their business within the competitive market.

Drivers and Restraints Impacting the Market

Over the past few years, reliance on drugs and medicines have increased significantly. With increased demand for innovative drugs and limited number of blockbuster drugs, large pharmaceutical companies are trying to stay competitive by conducting faster drug development with corresponding cost containment. Moreover, after the regulatory approval of drug, companies are left with less time to deliver drug in the market in considerable quantity. Such factors are leading to greater outsourcing of manufacturing facilities to contract manufacturers. Influx of virtual and small startups with negligible manufacturing capacity is further propelling the market growth during the assessment period. Also, rising demand for next-generation biological therapies is opening doors for manufacturers, thereby driving the market across the globe.

On the flip side, lack of manufacturing standardization and capacity utilization of issues are some of the major factors impacting the profitability of pharmaceutical contract manufacturing organizations. Moreover, increasing lead time and logistics costs are creating skepticism among pharmaceutical companies. This is further impeding the market growth across the globe.

Major Key Players:

top 10 pharmaceutical contract manufacturing companies are Grifols International, AbbVie Inc, Catalant, Patheon Inc., Lonza AG, Boehringer Ingelheim, Vetter, S.A, Pharmaceutical Product Development, and others.

Segment Analysis

The global pharmaceutical contract manufacturing market has been segmented on the basis of type.

By mode of type, the global pharmaceutical contract manufacturing market has been segmented into finished dosage formulation market, active pharmaceutical ingredient manufacturing, and others. Among these, the active pharmaceutical ingredient manufacturing dominates the global market owing to the restructuring of the pharmaceutical industry. Regulatory development in the market will let generic drug companies manufacture and develop products for export. Improvement in pharmaceutical manufacturing capabilities along with demand for specialized technologies is considered to steer few companies to return to sourcing APIs from the suppliers.

Regional Analysis

Geographically, the pharmaceutical contract manufacturing market span across regions namely, Asia Pacific, America, Europe, and the Middle East and Africa.

Among all the regions, the American region is presumed to dominate the global market due to well-developed technology, improvement in the reimbursement scenario, high expenditure on healthcare, and the presence of major market players.

Europe is considered to hold the second position in the global pharmaceutical contract manufacturing market and is estimated to maintain its dominance over the assessment period. The growth is attributed to the support provided by the government for research and development activities in this region.

The Asia Pacific region is estimated to be the fastest growing region during the assessment period owing to the rapidly improving technology and the presence of a huge patient population in this region. However, the Middle East and Africa hold the least share in the market due to the presence of slow and poor developing countries in this region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

AI in Drug Discovery Market Research Report- Forecast till 2030

 AI in Drug Discovery Market

The growth of the global AI in drug discovery market is driven by various factors such as investments by industry giants into the AI business, increasing number of startups operating in AI spectrum for healthcare including drug discovery, machine learning, and other AI technologies and increased use of AI technology by major pharma companies in the drug discovery.

AI in Drug Discovery Market is expected to hold a value of about USD 8.9 Billion by 2030, and it is projected to register a CAGR of 24.9% from 2022 to 2030.

In addition, the increasing number of cross-industry partnerships for achieving the common goal of improvement in the drug development outcomes is another factor for the growth of the AI in the drug discovery market. Below is the chart representing the number of AI-driven deals each of the Big Biopharma companies have disclosed till March 2019.

Major Key Players:

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others. 

Segment Analysis

The report is segmented into seven dynamics;

By Product Type     : Services and Software.

By Molecule Type: Large and Small Molecules.

By Technology         : Machine Learning, Deep Learning, and others.

By Indication           : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others.

By Application         : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others.

By End-User : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others.

By Regions                : Americas, Europe, Asia Pacific, and Rest-of-the-World. 

Regional Analysis

The artificial intelligence in medicine market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region is expected to be the largest market owing to the number of big AI platform developers present in the region, such as Microsoft Azure, TensorFlow, and Google AI. The market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. Increasing demand for AI solutions by the pharmaceutical players such as AbbVie, Genentech, Amgen, and Eli Lilly and Company, among others, is pushing the market growth in the region. The European AI in drug discovery market is the second-largest market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. High demand for AI platforms and increasing integration into the drug discovery by major players such as Novartis, AstraZeneca, GSK, BI, BMS, and Sanofi, among others, are expected to drive the growth of AI in drug discovery market in the European region.

The AI in drug discovery market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to increasing R&D activities in the region and increasing adoption of the AI technologies by the pharma companies in countries like China and India, the market in Asia-Pacific is expected to grow at a significant rate during the forecast. The AI in drug discovery market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Electric Wheelchair Market Research Report - Global Forecast till 2030

 Electric Wheelchair Market

Electric wheelchairs get power from an electric motor that comes attached with the electric wheelchair. These wheelchairs offer great mobility and are light in weight. These are very compact in size and can be used in narrow pathways. The global electric wheelchair market is expecting substantial market growth during the forecast period (2019-2023). Market Research Future (MRFR) made a claim recently that the global electric wheelchair market can surpass the existing market valuation with relative ease.

Electric Wheelchair Market size is expected to reach USD 6.47 Billion by 2030 at 6.8% CAGR during the forecast period 2022-2030.

The electric wheelchair market is expecting strong support from various pointers for a better market growth. It is expecting strong growth due to competitors participating more and more in the market to take the market ahead with their strategic moves. Its easy application is fast gaining momentum. Latest innovations are also helping the global market in its growth opportunity. However, high price and maintenance complexity can deter the global electric wheelchair market growth in the coming years.

Major Key Players:

MRFR recognizes the following companies as the Key Players in the Global Electric Wheelchair Market— GF Health Products, Inc. (US), Sunrise Medical (Germany), Quantum Rehab (US), Permobil AB (Sweden), Pride Mobility Products Corp (US), Invacare Corporation, Drive Medical (US), Ottobock (Germany), Levo AG (Switzerland), and Karman Healthcare, Inc. (US).

Segment Analysis

MRFR’s report of the global electric wheelchair market has an in-depth eye on segmentation that can impact the market in the coming years. Such a segmentation has its roots in the value-wise and volume-wise analysis of factors that can impact of the market.

Based on the electric wheelchair types, the electric wheelchair market comprises electric outdoor chair, electric indoor chair, center wheel drive chair, dual-purpose chair, front wheel drive chair, rear wheel drive chair, standing electric wheelchair, and others. The electric indoor chair segment has substantial market coverage. In many countries, lack of outdoor infrastructure can put some restraints on the expected market growth.

Based on the end-use, the electric wheelchair market comprises home care settings, hospitals/clinics, and others. The home care settings market is gaining remarkable coverage with many patients are looking for recovery from such setups.

Regional Analysis

Global Electric Wheelchair Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019. The technological advancement in the electric wheelchair with attachment of gadgets for control and accessibility majorly drive the market growth. Also, the rise in purchasing power, increasing geriatric population, and inclination towards more refined technology have been driving the progress of the electric wheelchair market in the region.

The European electric wheelchair market has been further segmented into Western Europe and Eastern Europe. The Western Europe electric wheelchair market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. Europe held the second-largest position in the electric wheelchair market with a market share of 29.3% in 2019 and anticipated to witness significant growth over the forecast period due to a higher number of patients and the availability of products in the region. Europe is also expected to have high growth in the electric wheelchair market, owing to the rising number of physically challenged people in the region.

Asia Pacific is anticipated to register the highest growth rate with a CAGR value of 8.5% over the forecast period from 2020 to 2030. According to the United Nations, across Asia, the number of people age 65 and above is expected to grow dramatically over the next 50 years. Moreover, the increasing disposable income of middle-class families, which accounts for a large population in Asia, encouraging them to spend more on health, is driving the growth of the electric wheelchairs market in the region.

The Middle East & Africa electric wheelchair market is segmented into the Middle East and Africa. The growth of the electric wheelchair market in the Middle East and Africa is growing steadily in the past few years. Increasing the prevalence of orthopedics disorders and funding by private players and government bodies is propelling the market growth in this region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com